Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Editorial Board

Partnerships

Articles

A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.

Emerging multiplex UTI testing drives Medicare costs amid increased utilization

A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.

Reduced cost-effectiveness reported from HPV vaccination in mid-adults

Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.

Reduced subsequent births reported after severe maternal morbidity

Discover how innovative self-collection methods and the BD Onclarity HPV assay are breaking barriers in cervical cancer screening, empowering underserved communities with accessible and accurate care.

Transforming cervical cancer protection with the BD Onclarity HPV Assay

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Facebook

LinkedIn

RSS Feed

Spotlight

A Psychedelic to Treat Postpartum Depression?

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

View

Expert Perspectives on Cervical Cancer and STI Screenings

Importance of STI Screening to Detect Uncommon Infections

Video content above is prompted by the following:

Please provide an overview of vaginitis and different screening options.

What are the key features and benefits of utilizing nucleic acid amplification testing for vaginitis vs other screening options?

What strategies can be implemented to improve awareness and education surrounding vaginitis and its testing options?

Can you please provide an overview of the following STIs and their screening options?

Kameelah Phillips, MD, FACOG, NCMP, explores comprehensive strategies for improving detection, management, and patient education surrounding vaginitis, sexually transmitted infections (STIs), and cervical cancer, emphasizing the importance of advanced screening methods, health care provider–patient communication, and empowering individuals to advocate for their sexual health.

Kameelah Phillips, MD, FACOG, NCMP, discusses how advances in molecular testing have improved the diagnosis and management of vaginitis and sexually transmitted infections like Mycoplasma genitalium and trichomoniasis, emphasizing the importance of education and awareness to promote better screening practices.

Importance of STI Screening to Detect Uncommon Infections

EP: 1.Importance of STI Screening to Detect Uncommon Infections